The global CLL therapeutics market is estimated at USD 8.5 B in 2023 and projected to reach USD 15.9 B by 2032—growing at a CAGR between 7.3 % and 7.9 %, fueled by targeted therapies, immunotherapies, and aging populations. https://www.datamintelligence.com/research-report/chronic-lymphocytic-leukemia-therapeutics-market